Development of vaccines for Plasmodium vivax malaria

Abstract Plasmodium vivax continues to cause significant morbidity outside Africa with more than 50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central and South America being attributed to P. vivax infections. The unique biology of P. vivax , including its ability...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2015-12, Vol.33 (52), p.7489-7495
Hauptverfasser:	Mueller, Ivo, Shakri, Ahmad Rushdi, Chitnis, Chetan E
Format:	Artikel
Sprache:	eng
Schlagworte:	Africa Allergy and Immunology Biomedical Research Blood stage malaria vaccines Drug dosages Drug resistance Government agencies Humans Immunity to malaria Infections Life Cycle Stages - immunology Liver Malaria Malaria vaccines Malaria Vaccines - immunology Malaria, Vivax - immunology Malaria, Vivax - prevention & control Malaria, Vivax - transmission Mosquitoes P. vivax malaria Pacific Islands Parasitic diseases Plasmodium vivax Plasmodium vivax - immunology Plasmodium vivax - physiology Pre-erythrocytic stage malaria vaccines Prevention Proteins South America Transmission blocking malaria vaccines Vaccines Vector-borne diseases Vectors (Biology)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!